ICHOR Biologics is hiring Executive and Senior Executive professionals for QC Microbiology and QC Biologics, with 2–6 years of relevant experience. Immediate joiners are preferred. Walk-in interviews will take place on 14 and 15 November 2026, from 10:00 a.m. to 3:00 p.m., at ICHOR Biologics Pvt. Ltd., Genome Valley, Thurkapally, Hyderabad, Telangana. Relevant industry experience is preferred; applications are open to male candidates.
We are hiring for following positions
QC-Microbiology
Designation: Executive / Senior Executive
Experience: 2 – 6 Years
Qualification: M.Sc. (Microbiology/ Biotechnology), BET, MLT, Sterility & Bioburden Testing
Key Responsibilities & Requirements
- Perform routine microbiological testing of raw materials, in-process samples, finished products and environmental monitoring samples.
- Maintain aseptic area techniques and laboratory practices.
- Interpret results and maintain records as per cGMP/GDP guidelines.
- Support method validation, investigations and documentation activities.
- BET (Bacterial Endotoxin Testing), MLT (Microbial Limit Testing), Sterility Testing, Bioburden Testing
QC Biologics
Designation: Executive / Senior Executive
Experience: 2–6 Years
Qualification:
- M.Sc. (Biotechnology/ Biochemistry)
- B Tech/ M Tech (Biotechnology)
Key Responsibilities & Requirements
- Perform analytical testing of raw materials, intermediates and finished products.
- Operate and maintain instruments like HPLC, ELISA Reader, Spectrophotometer, Kjeldahl equipment, pH Meter, Analytical Balance etc.
- Good knowledge on QC related techniques and regulatory documentation will be preferred.
Walk-in interview details
Walk-In Dates: 14th , 15th November 2026
Time: 10:00 AM – 3:00 PM
Venue: ICHOR Biologics Private Limited, Genome Valley, Thurkapally, Hyderabad, Telangana.
Send your updated resume to: careers@ichor.in
📢 Immediate joiners preferred. Open to male candidates, with relevant industry experience preferred.
About ICHOR Biologics Pvt Ltd
Ichor Biologics Private Limited is a research-based, specialty biopharmaceutical company headquartered in the Genome Valley biotech hub of Hyderabad, India. Originally rooted in operations dating back to 2011, the company was formally incorporated under its current structure in March 2021 after acquiring the biopharma assets of Hemarus Therapeutics Limited. The firm focuses primarily on the innovation, development, and global commercialization of high-purity, human plasma-derived therapeutics. Operating an integrated, current Good Manufacturing Practice (cGMP) compliant facility, Ichor Biologics specializes in supplying critical healthcare solutions across a broad spectrum of medical needs, including immunology, critical care, wound healing, and bleeding disorders like hemophilia. Bolstered by multiple patents granted in both India and the United States, the company’s commercial reach extends to over 20 countries, leveraging plasma fractionation to provide affordable, life-saving alternatives for severe and rare clinical conditions. (Note: This entity is distinct from a pre-clinical, NYC-based biotechnology company that shares the name Ichor Biologics but focuses on infectious disease antibody platforms).
